# Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally

> **NCT05937113** · PHASE4 · COMPLETED · sponsor: **Vietnam Military Medical University** · enrollment: 220 (actual)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** RABIVAX-S

## Key facts

- **NCT ID:** NCT05937113
- **Lead sponsor:** Vietnam Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-13
- **Primary completion:** 2020-07-02
- **Final completion:** 2020-10-30
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2023-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937113, "Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05937113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*